Amagma Therapeutics
Waltham
About Amagma Therapeutics
Amagma Therapeutics is a biotechnology company that specializes in the discovery and development of antibody therapeutics against inflammatory diseases. Its technology overactive extracellular proteases trigger tissue damage that can sustain broad inflammatory responses. The company was founded in 2019 and headquartered in Waltham, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $18.6M
- Last round: Series Unknown (Jun 2022)
- Website: amagmatx.com
- Phone: 781 472 2230
Industries & Categories
Biotechnology, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/amagma-therapeutics-46842 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.